A new technology that delivers two halves of a gene separately could enable gene therapy treatments of muscular dystrophies.

The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult ...

Gene therapy can effectively treat various diseases, but for some debilitating conditions like muscular dystrophies there is a big problem: size. The ...

With over 100 publications in international journals, his groundbreaking work has earned him ... In 2014, he founded VectorBuilder, a revolutionary online platform for vector design and ordering that ...

Electronic execution desks at banks offer a large number of trading algorithms to clients. These algorithms may differ in the venues they trade on, the speed at which they trade, the aggressiveness of ...

Historically an active player in the M&A space, Radnor-based Avantor has not found itself so busy in that realm during the ...

StitchR, a new gene therapy technique, delivers large genes in two parts to treat muscular dystrophies by restoring critical proteins in animal models.

Emily McDermott, an entomology researcher, and Blythe Lawson, a Ph.D. student, tested fluralaner, a product commonly used to treat ticks and fleas on pets, to successfully target fly and mosquito ...

Jason Farned and his team at the San Gabriel Valley Mosquito and Vector Control District had spent years preparing for the ...

In a paper published in the journal Nature Physics, researchers used a superconducting quantum simulator to emulate charged ...

Diamond-Blackfan anemia (DBA) is a potentially life-threatening condition that can cause severe anemia and other abnormalities. It's a rare genetic blood disorder that occurs when the bone marrow ...